Disease | multiple myeloma |
Phenotype | C0004030|aspergillosis |
Sentences | 1 |
PubMedID- 23125547 | In addition, although some autologous hsct recipients are at high risk for developing invasive aspergillosis (especially patients with multiple myeloma having received intensive chemotherapeutic regimens before transplant)(49), no formal recommendations can be made regarding anti-mould prophylaxis in this setting. |
Page: 1